MedPath

Comparison of the effect of Hibiscus sabdariffa L. extract and thiazide on treatment of hypertension in patients with mild chronic kidney disease : A randomized controlled clinical trial: double blinded

Phase 3
Recruiting
Conditions
Patients with hypertension with mild renal failer.
Hypertensive chronic kidney disease
Registration Number
IRCT20210926052600N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

1. Non-pregnant man or woman 18 to 70 years old
2. Consent to participate in the study
3. A patient with confirmed clinical signs of hypertension with mild renal failure
4. Abnormal blood pressure (=> 130/80 according to AHA criteria)
5. Patient follow-up

Exclusion Criteria

1- Allergy to the plant
2- Normal blood pressure (mm HgSBP = 120; DBP = 80 mm Hg) / blood pressure below 100 and blood pressure => 160/100
3- Patients with diabetes mellitus, severe renal failure, coronary artery disease, heart failure, malignant hypertension [BP = 180/110], etc.)
4- Study of changing antihypertensive drugs in patients
5- Systolic blood pressure below 100 during the study
6- Pregnancy
7. Any metabolic or malabsorption disease that may interfere with the absorption of hibiscus (such as celiac disease, chronic pancreatitis, etc.).
8- Use of psychiatric drugs (mood stabilizer, anti-depressant, anti-anxiety or anti-psychotic

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients' blood pressure changes,, albuminuria and proteinuria. Timepoint: Blood pressure at the beginning and 3 months after the intervention. Method of measurement: Based on laboratory Examination.;Electrolytes. Timepoint: Electrolytes at the beginning and 3 months after the start of the intervention. Method of measurement: Based on laboratory Examination.;Albuminuria and proteinuria. Timepoint: albuminuria, proteinuria, GFR according to MDRD formula. Method of measurement: Based on laboratory Examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath